recombinant human biologic lymphocyte activation gene-3 inhibitor (Lipid Genomics)

N/A

Report date: 2025/03/20 09:17:21

Base Information

Drug Namerecombinant human biologic lymphocyte activation gene-3 inhibitor (Lipid Genomics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsCholesterol modulators
TargetsLymphocyte activation gene 3 proteinCholesterol
Therapy Area/IndicationsCholesterol metabolism disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLipid Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipid Genomics Inc
Inactive CompaniesN/A
Active IndicationsCholesterol metabolism disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A